il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...
il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...
il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
causing <strong>the</strong> increased leakage <strong>of</strong> electrons gener<strong>at</strong>ed by <strong>the</strong> oxid<strong>at</strong>ive phosphoril<strong>at</strong>ion<br />
process. These electrons will rapidly react with molecular oxygen producing reactive<br />
oxygen species (ROS) (Gille and Nohl 1997). Ano<strong>the</strong>r p<strong>at</strong>hway <strong>of</strong> adriamycin-induced<br />
apoptosis was described in isol<strong>at</strong>ed adult cardiac myocytes (Andrieu-Abadie et al.1999;<br />
Henaff et al. 2002). Adriamycin has a potential tp activ<strong>at</strong>e acidic sphlingomyelinase<br />
which will result in <strong>the</strong> increased production <strong>of</strong> ceramide (Andrieu-Abadie et al. 1999).<br />
The increase in <strong>the</strong> intracellular levels <strong>of</strong> ceramide will lead to <strong>the</strong> activ<strong>at</strong>ion <strong>of</strong><br />
mitochondrial membrane voltage-independent B type calcium charmels which will result<br />
in <strong>the</strong> opening <strong>of</strong> mitochondrial transition pores and release <strong>of</strong> cytochrome C (Andrieu-<br />
Abadie et al. 1999). This hypo<strong>the</strong>sis is confirmed by <strong>the</strong> reports th<strong>at</strong> carnitine, an<br />
inhibitor <strong>of</strong> acid sphl'ngomyelinase, has a potential to inhibit adriamycin-induced<br />
apoptosis.<br />
Adriamycin administr<strong>at</strong>ion was also found to cause <strong>the</strong> activ<strong>at</strong>ion <strong>of</strong> proapoptotic<br />
factor-p38 mitogen activ<strong>at</strong>ed protein kinases (MAPK), while <strong>the</strong> inhibitors <strong>of</strong> p38 MAPK<br />
were found to prevent <strong>the</strong> occurrence <strong>of</strong> adriamycin-induced apoptosis in cardiac<br />
myocytes (Kang et al. 2000b). Adriamycin-induced activ<strong>at</strong>ion <strong>of</strong> p38 was prevented by a<br />
cardiac-specific overexpression <strong>of</strong> antioxidant compounds met<strong>at</strong>allothioenins thus linking<br />
<strong>the</strong> adriamycin-induced oxid<strong>at</strong>ive stress with p38 initi<strong>at</strong>ed apoptosis in cardiac myocytes<br />
(Kang et al. 2000b).<br />
The involvement <strong>of</strong> oxid<strong>at</strong>ive stress in <strong>the</strong> p<strong>at</strong>hogenesis <strong>of</strong> adriamycin-induced<br />
apoptosis in isol<strong>at</strong>ed cardiac myocytes was also confirmed in a study where tre<strong>at</strong>ments<br />
with antioxidant trolox prevented <strong>the</strong> development <strong>of</strong> adriamycin-induced apoptosis<br />
(Kumar et al. 1999). It is interesting to mention th<strong>at</strong> <strong>the</strong> exposure <strong>of</strong> isol<strong>at</strong>ed cardiac<br />
t5